Slide 1: Second Quarter 2023 Earnings
Second Quarter 2023 Earnings July 27, 2023 1
Slide 2: Agenda
Agenda IDEX Business Update Q2 2023 Financial Performance Segment Performance 2023 Guidance Summary Closing Remarks Q&A IDEX Proprietary & Confidential 2
Slide 3: Replay Information
Replay Information • Dial toll–free: 877.660.6853 • International: 201.612.7415 • Conference ID: #13734463 • Log on to: www.idexcorp.com IDEX Proprietary & Confidential 3
Slide 4: Cautionary Statement
Cautionary Statement Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other
Slide 5: Business Update
Business Update IDEX Proprietary & Confidential 5
Slide 6: IDEX Overview
IDEX Overview Second Quarter Results: • Record sales and Adjusted EPS • Growth across FMT/FSD; HST markets remain challenged • Completed acquisition of Iridian Spectral Technologies Looking Ahead: • Industrial downturn and softening HST key markets • Revised full year adjusted EPS guidance to $7.90-
Slide 7: Financials
Financials IDEX Proprietary & Confidential 7
Slide 8: Strong Revenue, Earnings, and Free Cash Flow
IDEX Q2 2023 Financial Performance (Dollars in millions, excl. EPS) Sales Adjusted Earnings per Share* 3% Organic* 8% Increase $796 $846 $2.02 $2.18 Q2'22 Q2'23 Q2'22 Q2'23 Adjusted EBITDA Margin* Free Cash Flow* +90 bps 24% 28.4% $120 $97 27.5% Q2'22 Q2'23 Q2'22 Q2'23 Strong Revenue, Earnings, and
Slide 9: Q2 2023 Adjusted EBITDA Walk
Q2 2023 Adjusted EBITDA Walk (Dollars in millions) 9 $ 241 20 5 0 (3) $ 219 (9) 2Q'22 ACT Organic Price / Mix Resource Variable Acq/Div/ 2Q'23 ACT ADJ EBITDA* Flow Thru Productivity / Investment / Compensation FX ADJ EBITDA * Inflation Discretionary Flow through Organic flow Total flow @ PY GM%* thr
Slide 10: IDEX 2Q 2023 Segment Performance
IDEX 2Q 2023 Segment Performance Fluid & Metering Technology Health & Science Technology Fire & Safety / Diversified Q2 Revenue $325M / 38% of Total Q2 Revenue $340M / 40% of Total Q2 Revenue $185M / 22% of Total • Slowing Industrial Orders • Pressure across AI/Life Sciences • Strong Fire and Rescue
Slide 11: 2023 Guidance Summary
2023 Guidance Summary Third Quarter Full Year Current Prior Current Guidance Guidance Guidance Revenue% vs. Prior Year Organic* (8%) - (7%) 0-3% (2%) - (1%) Adjusted EBITDA%* ~27% 27.5% - 27.9% ~27% Earnings per Share Reported $1.60 - $1.65 $7.30 - $7.60 $6.80 - $6.90 Adjusted* $1.84 - $1.89 $8.25 -
Slide 12: IDEX Portfolio Positioned for Growth
IDEX Portfolio Positioned for Growth SUSTAINABILITY TOP ORGANIC INDUSTRY 4.0 & GROWTH DIGITIZATION BETS Sustainable DEMOGRAPHIC Growth SHIFTS Outperformance EVOLVING GLOBAL DYNAMICS Best Organic + 8020 Dynamic + Complementary M&A Opportunities Resourcing IDEX PROPRIETARY & CONFIDENTIAL 1212
Slide 13: Appendix
Appendix IDEX Proprietary & Confidential 13
Slide 14: Fluid & Metering Technologies
Fluid & Metering Technologies (Dollars in millions) Orders Sales Adjusted EBITDA Margin* -4% Organic* 10% Organic* +340 bps* $319 $300 $325 31.7% 35.1% $303 Q2'22 Q2'23 Q2'22 Q2'23 Q2'22 Q2'23 Q2 Sales Mix: Organic 10% Q2 Highlights: Slowing Industrial Orders Acquisition/Divestiture (1%) Strong
Slide 15: Health & Science Technologies
Health & Science Technologies (Dollars in millions) Orders Sales Adjusted EBITDA Margin* -27% Organic* -6% Organic* -420 bps* $343 31.8% $326 $340 27.6% $285 Q2'22 Q2'23 Q2'22 Q2'23 Q2'22 Q2'23 Q2 Sales Mix: Organic (6%) Q2 Highlights: Pressure across Analytical Instrumentation and Life Science Ma
Slide 16: Fire & Safety / Diversified Products
Fire & Safety / Diversified Products (Dollars in millions) Orders Sales Adjusted EBITDA Margin* 2% Organic* 8% Organic* +300 bps* $177 $179 $185 29.4% $171 26.4% Q2'22 Q2'23 Q2'22 Q2'23 Q2'22 Q2'23 Q2 Highlights: Q2 Sales Mix: Organic 8% Strong Fire and Rescue FX 0% Mixed global paint market wit
Slide 17: Non-GAAP Reconciliations
Non-GAAP Reconciliations IDEX Proprietary & Confidential 17
Slide 18: < -*8# "*ÿ "ÿ! &ÿ "" !$#" $%ÿ"ÿ?;@Aÿ! ÿ& %&#% "*ÿ ÿB"ÿ! &ÿ "" !$#" $%ÿ"ÿ?;@Aÿ%# ÿ %# ÿ &>#! !"! 3 …
01234556ÿ89 9 ÿ1ÿ2 2ÿ691 29 ÿÿÿ!"ÿ#$%!&ÿ'!&!%ÿ"""ÿ!ÿ&'!"ÿ(!"ÿ&&#"!)ÿ!&!%ÿ)%%ÿ &&"*ÿ!ÿ"ÿ+!"*ÿ,""ÿ'ÿ-!&ÿ./--012ÿÿÿ#%"ÿ&"!ÿ/--0ÿ'!&!%ÿ '&ÿ"!&ÿ(!"ÿ3/--0ÿ'!&!%ÿ'&ÿ"!&2ÿ4)"ÿ$%!5ÿ"ÿ3 /--0ÿ'!&!%ÿ'&ÿ"!&ÿ5!*ÿ!5"ÿ(!"ÿ)"ÿ!!)"6ÿ"&ÿ*ÿÿÿ &!5ÿ#*"*!)ÿ'ÿ"ÿ'!&!%ÿ!'"!ÿ#*ÿ$ÿ)"ÿ!ÿ!"ÿ'!&!%ÿ*ÿ "!%ÿ*&!!ÿ7!)ÿamp;#ÿ&"!ÿ'ÿ"ÿ*8#"
Slide 19: DÿEF0 ÿGFH+!ÿ0%G!%&$ Iÿ'&!4J+4ÿK F L!' O)P+'&!)ÿL #039;'ÿ4 $50& S!&ÿ'FH!'
01234ÿ67ÿ849 931 ÿÿ84 4 4ÿÿÿ1 ÿ1 ÿ 331ÿ ÿ 33 !!ÿ#$%&'ÿ(%)!)ÿ*+%!ÿ,-. /01ÿ#$%&'ÿ(%)!)ÿ*+%!ÿ,-. 2-2, 2-22 2-2, 2-22 3 #039;'ÿ4$50& 6ÿ ,789-ÿ :ÿ <=>?@ÿ 6ÿ 7A-9Bÿ :ÿ >@@?Cÿ DÿEF0ÿGFH+!ÿ0%G!%&$Iÿ'&!4J+4ÿKFL!' ÿ Mÿ ÿ N?Cÿ ÿ Mÿ ÿ N?Cÿ O)P+'&!)ÿL#039;'ÿ4$50& 6ÿ ,789-ÿ :ÿ <=Q?<ÿ 6ÿ 7A-9Bÿ :ÿ >@@?Rÿ S!&ÿ'FH!' 6ÿ 8T
Slide 20: XHY ÿ nopqorostrÿuÿqoroqvoÿqowxqyoyÿxsÿusÿzsvort{ostÿ|zt}ÿuÿwx~~uxqutzvoÿpuqtsoqÿt}utÿ{uÿsxÿ~xsoqÿoÿqowxvoqu~oI TI
01234ÿ67ÿ849 931 ÿ ÿ84 4 4ÿ4ÿ9 4ÿ1 ÿ34ÿÿ ÿ 33 ÿ4 94ÿ4ÿ!14ÿ 1 "ÿ# 4" $%&''ÿ)*+,%-ÿ.+/'/ÿ01+'ÿ234 567ÿ)*+,%-ÿ.+/'/ÿ01+'ÿ234 8382 8388 8382 8388 9':*&,'/ÿ/6;1,'/ÿ.<5ÿ=,,&6>1,=>;'ÿ,*ÿ?@.A Bÿ CDE8ÿ Fÿ HIJHÿBÿ 2DKKÿFÿ LIMNÿ ÿOÿ9'-,&1P,1&6+Qÿ'7:'+-'-ÿ=+/ÿ=--',ÿ6R:=6&R'+,- ÿ 3D3Sÿ ÿ TITUÿÿ 3D3Kÿÿ TITUÿ ÿOÿ$
Slide 21: `Sa ÿ qrstrurnvuÿwÿtrurtxrÿtryzt{r{ÿznÿwnÿ|nxruvprnvÿ}|v~ÿwÿyzwztwv|xrÿswtvnrtÿv~wvÿpwÿnzÿznrtÿrÿtryzxrtwr `…
01234ÿ67ÿ849 931 ÿÿ4ÿ9 4ÿ ÿ4ÿ0ÿ 331ÿ ÿ 33 ÿÿ 4 ÿ"#$%&'ÿ($)*)ÿ+,$*ÿ-./ 0.0- 0.00 1"2 32 145 6#78#79%* :4(; 1"2 32 145 6#78#79%* :4(; <*8#7%*)ÿ$*%ÿ$=#>* ?ÿ @ÿ ?ÿ @ÿ ?ÿ @ÿ ?ÿ @ÿ ?ÿ0ABC-ÿ Dÿ Fÿ Dÿ Fÿ Dÿ Fÿ Dÿ Fÿ DÿGHIJKÿ Lÿ57#M'#$ÿN#7ÿ$=#>*ÿ%9 *' ÿ @ÿ ÿ @ÿ ÿ @ÿ ÿ @ÿ ÿB.C.ÿ ÿ Fÿ ÿ Fÿ ÿ Fÿ ÿ Fÿ ÿHOJPÿ Lÿ:
Slide 22: abcdbebfgeÿhÿdbebdibÿdbjkdlblÿkfÿhfÿmfibegnbfgÿomgpÿhÿjkqqhrkdhgmibÿchdgfbdÿgphgÿnhsÿfkÿqkftbdÿrbÿdbjkibdhrqbA
01234ÿ67ÿ849 931 ÿÿ 14ÿÿ4ÿ9 4ÿ ÿ4ÿ0ÿ 331ÿ ÿ 33 !"#$%&' ()"*#ÿ,!$*-'*ÿ./.0 1!22ÿ3'$*ÿ./.0 456ÿ7%# 8"9)ÿ7%# 456ÿ7%# 8"9)ÿ7%# :';5*-'#ÿ%'-ÿ"%&5<' =ÿ ?@?ABÿ =ÿ ?@CADÿ =ÿ D?EAEÿ =ÿ D@CA?ÿ FÿG*5H"I"5%ÿJ5*ÿ"%&5<'ÿ-$K'I ÿ BDALÿ ÿ BEALÿ ÿ ?CMAMÿ ÿ ?D?ALÿ FÿN%-'*'I-ÿ'K;'%I' ÿ ?CALÿ ÿ ?CALÿ ÿ DCACÿ ÿ DCACÿ FÿO